INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

4,771 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

An expert overview of the literature, useful as background reading.

323 studies · page 1 of 14

2023 / Narrative review

A review outlines the benefits and uncertainties of new weight loss drugs, noting profound caloric reductions may warrant nutritional deficiency testing.

This review evaluates the pros and cons of newer weight loss medications like semaglutide and tirzepatide, noting short-term weight losses of -15% to -20% from baseline. The authors note that profound caloric reductions from these medications should prompt baseline or ongoing nutritional deficiency testing and dietary recommendations. However, long-term adherence, cost, access, supply chain issues, and long-term impacts on mental and physical health remain unknown.

Moyad MA Curr Urol Rep, 2023. PMID 37659049

2023 / Narrative review

A review outlines therapeutic milestones in obesity management, including leptin, melanocortin agonists, incretins, and metabolic surgery.

This review summarizes scientific milestones and therapies developed to address obesity and its cardiometabolic comorbidities. It highlights key developments starting from the discovery of leptin, melanocortin receptor agonists for syndromic obesity, incretin therapies including GLP-1 analogs and unimolecular combinations, and metabolic and bariatric surgery. The authors emphasize that this expanding therapeutic armamentarium warrants a coordinated multidisciplinary approach, such as cardiometabolic expertise centers, to address obesity and its complications.

Kokkorakis M, Katsarou A, Katsiki N, et al. Metabolism, 2023. PMID 37689110

2022 / Narrative review

GLP-1 receptor agonists are effective for obesity and T2DM, but their therapeutic effects are not fully congruent with endogenous GLP-1 actions.

This review examines the physiological functions of GLP-1 and its development into pharmaceuticals for obesity and type 2 diabetes (T2DM). GLP-1 receptor agonists are highlighted as effective anti-obesity agents and recommended second-line therapies for T2DM, particularly for patients with increased cardiovascular risk. The author discusses proglucagon processing across tissues and notes that the relationship between endogenous GLP-1 actions and the clinical effects of agonists is far from congruent and generally poorly understood.

Holst JJ J Intern Med, 2022. PMID 34982496

2020 / Narrative review

Hospitals can serve as models for dietary change by using patient experiences to educate on lifestyle and optimal nutrition.

Poor dietary quality is a primary contributor to US mortality and cardiovascular risk factors. Hospitals have an opportunity to utilize the patient experience as a teachable moment by educating on lifestyle and dietary changes. Additionally, the food choices offered to inpatients and outpatients can establish a paradigm for patients to adopt following discharge, with several US hospitals demonstrating novel initiatives.

Aggarwal M, Grady A, Desai D, et al. Am J Med, 2020. PMID 31494109

2020 / Narrative review

Potassium-enriched salt substitutes lower systolic and diastolic blood pressure, but evidence on hyperkalemia risk remains insufficient.

This review evaluated the benefits and risks of replacing sodium chloride with potassium-enriched salt substitutes. Empirical evidence shows that this replacement lowers systolic blood pressure by an average net delta of -5.58 mm Hg (95% CI: -7.08 to -4.09) and diastolic blood pressure by -2.88 mm Hg (95% CI: -3.93 to -1.83). Potential risks include hyperkalemia, arrhythmias, and sudden cardiac death, especially in individuals with impaired potassium excretion such as chronic kidney disease. However, the authors note there is currently insufficient evidence regarding the effects of these substitutes on the occurrence of hyperkalemia.

Greer RC, Marklund M, Anderson CAM, et al. Hypertension, 2020. PMID 31838902

2020 / Commentary / narrative review

A commentary critiques recent recommendations on red and processed meat, highlighting evidence for cardiovascular and cancer risks.

This commentary criticizes five papers in the Annals of Internal Medicine that advised no need to reduce red or processed meat consumption based on low-certainty evidence from randomized trials and cohort studies. The author argues that red meat is a probable human carcinogen, processed meat is a definite carcinogen, and saturated fat raises heart disease risk. Additionally, the piece notes that vegetarians and vegans display superior lipid profiles, decreased chronic disease risk, and longer lifespans compared to meat eaters.

Potter JD, Jackson R Nutr Cancer, 2020. PMID 31842617

2020 / Narrative review

Plant-based and vegan diets are linked to lower disease incidence, though mortality rates are comparable to vegetarians and occasional meat eaters.

This review examined studies addressing mortality, health-span, and longevity-enhancing mechanisms in vegans and vegetarians. Epidemiologic studies consistently show lower disease rates, such as lower cancer and cardiovascular disease incidence, but mortality rates are comparable to vegetarians and occasional meat eaters. Vegan diets improve insulin resistance and dyslipidemia, and features like protein restriction or amino acid restriction (leucine or methionine) show potential life-span-enhancing effects. The review notes that vegan diets do not meet the nutritional requirements of children, pregnant women, or elderly individuals without adequate supplementation.

Shows an association, not proof of cause and effect.

Norman K, Klaus S Curr Opin Clin Nutr Metab Care, 2020. PMID 31895244

2020 / Narrative review

A whole food plant-based diet may offer benefits that slow chronic kidney disease progression and delay kidney failure.

This review examines the potential of a whole food plant-based (WFPB) diet to ameliorate chronic kidney disease (CKD). Evidence suggests a WFPB diet may slow CKD progression, decrease cardiovascular disease incidence, lower rates of diabetes and obesity, and reduce inflammation and cholesterol, thereby delaying kidney failure and dialysis initiation. Plant-based protein is reported to be alkaline-producing, anti-inflammatory, and renoprotective, contrasting with animal protein which promotes acidity, inflammation, and hyperfiltration. The authors note that macronutrient and micronutrient content must be carefully adjusted to prevent malnutrition, and further research is required to confirm biological plausibility and feasibility in CKD patients.

Adair KE, Bowden RG Nutrients, 2020. PMID 32268544

2020 / Narrative review

A review indicates high sodium intake is directly related to increased blood pressure, target organ damage, and elevated cardiovascular risk.

This review examines evidence on sodium intake and target organ damage in hypertension. The authors report that current global sodium consumption exceeds safe levels and that sodium intake is directly related to increased blood pressure and independently to cardiac mass enlargement. High sodium intake may also induce renal damage progression in both hypertensive and normotensive individuals and play an adverse role in cerebrovascular disease.

Nista F, Gatto F, Albertelli M, et al. Int J Environ Res Public Health, 2020. PMID 32325839

2020 / Guideline

The American Cancer Society updated its diet and physical activity guidelines for cancer prevention, adding community action recommendations.

The American Cancer Society updated its Diet and Physical Activity Guideline based on current scientific evidence regarding dietary and physical activity patterns and cancer risk. The guideline presents 4 recommendations for individual choices alongside recommendations for community action to create supportive environments. These recommendations align with prevention guidelines for coronary heart disease and diabetes from the American Heart Association and the American Diabetes Association.

Rock CL, Thomson C, Gansler T, et al. CA Cancer J Clin, 2020. PMID 32515498

2020 / Narrative review

A review notes lifestyle modifications like low sodium diet and weight loss can help control hypertension in African Americans.

This review examined literature from PubMed, guideline reports, and newer publications regarding hypertension and COVID-19 in African Americans. It highlights that the increased prevalence and risks of hypertension are primarily due to environmental and lifestyle factors, such as poor diet and adverse social determinants. Blood pressure control can be supported through lifestyle changes, including a low-sodium diet, weight loss, and physical activity, alongside pharmacological or novel treatments when needed. Additionally, existing comorbidities like hypertension and obesity contribute to worse COVID-19 outcomes in this population.

Ferdinand K, Batieste T, Fleurestil M J Natl Med Assoc, 2020. PMID 32563685

2020 / Narrative review with systematic search

A review of 43 studies found ultra-processed food consumption was linked to at least one adverse health outcome in 37 studies, with no beneficial outcomes found.

This narrative review systematically searched and appraised studies examining associations between ultra-processed food (UPF) intake and health outcomes in healthy participants. Out of 43 reviewed studies, 37 found UPF exposure was associated with at least one adverse health outcome. In adults, reported associations included overweight, obesity, cardio-metabolic risks, cancer, type-2 diabetes, cardiovascular diseases, irritable bowel syndrome, depression, frailty conditions, and all-cause mortality; in children and adolescents, outcomes included cardio-metabolic risks and asthma. No study reported an association between UPF and beneficial health outcomes, and the authors note that most findings were derived from observational studies.

Shows an association, not proof of cause and effect.

Elizabeth L, Machado P, Zinöcker M, et al. Nutrients, 2020. PMID 32630022

2019 / Narrative review

Increasing potassium intake lowers blood pressure, especially in hypertensive individuals, and reduces stroke risk by about 25%.

This review evaluates evidence on potassium intake for blood pressure control in essential hypertension and its safety in chronic kidney disease. Over 40 years of evidence demonstrates that increasing potassium intake through foods or supplements is associated with significant reductions in systolic and diastolic blood pressure, particularly in hypertensive patients and those with high sodium intake. Meta-analyses confirm high potassium intake reduces stroke risk by ~25%, and post hoc analyses suggest it may slow renal decline in early CKD. However, high potassium intake may be risky in hypertensive patients with CKD stages 3-5, specifically diabetics, though more prospective studies are needed.

Burnier M Nephrol Dial Transplant, 2019. PMID 29301002

2019 / Narrative review of two prospective cohort studies

In AHS-2 and EPIC-Oxford cohorts, vegetarian diets were linked to lower cancer and mortality risks and substantially reduced greenhouse gas emissions.

Researchers reviewed publications from the AHS-2 and EPIC-Oxford cohorts to describe the dietary intakes, health effects, and environmental outcomes of vegetarian patterns. In AHS-2, vegans had a 16% reduced risk of all cancers, while vegans, vegetarians, and fish-eaters in EPIC-Oxford showed an 11-19% lower risk compared to non-vegetarians. Pesco-vegetarians in AHS-2 had significantly lower all-cause and ischemic heart disease mortality, and EPIC-Oxford fish-eaters had significantly lower all-cancer mortality versus non-vegetarians. Greenhouse gas emissions of equicaloric diets were 29% lower for vegetarian diets in AHS-2 and 47-60% lower for vegetarian/vegan diets in EPIC-Oxford compared to non-vegetarian/meat-eating diets.

Shows an association, not proof of cause and effect.

Segovia-Siapco G, Sabaté J Eur J Clin Nutr, 2019. PMID 30487555

2019 / Narrative review

Plant-based diets rich in healthy plant foods are linked to lower CVD risk, whereas less healthy plant foods are associated with increased risk.

This review evaluates definitions of plant-based diets and summarizes their associations with cardiovascular disease risk, distinguishing between healthy and less healthy plant foods. Studies show that plant-based diets with higher intakes of healthy foods such as whole grains, fruits, vegetables, nuts, legumes, oils, tea, and coffee are linked to lower CVD risk. Conversely, plant-based diets high in less healthy plant foods like refined grains, potatoes/fries, and foods/beverages high in added sugar are linked to higher risk. The authors note that plant-based diets need not completely exclude meat or animal products to confer cardiovascular benefits.

Shows an association, not proof of cause and effect.

Hemler EC, Hu FB Curr Atheroscler Rep, 2019. PMID 30895476

2019 / Narrative review

High dietary salt adversely affects target organs including the heart, kidneys, brain, and bone, irrespective of blood pressure.

This review evaluates the blood pressure-independent physiological effects of dietary salt and controversies surrounding lower salt intakes and cardiovascular outcomes. High dietary salt has been shown to adversely affect the vasculature, heart, kidneys, skin, brain, and bone, mediated commonly by heightened inflammation and oxidative stress. The review also addresses the role of background diet in modulating the effects of salt.

Robinson AT, Edwards DG, Farquhar WB Curr Hypertens Rep, 2019. PMID 31025198

2019 / Case report and literature review

A whole food plant-based diet alongside medical therapy was followed by weight loss and normalized heart function in a patient with heart failure.

A 54-year-old female presenting with grade 3 obesity (BMI 45.2 kg/m2), type II diabetes (A1c 8.1%), and heart failure with depressed left ventricular systolic function transitioned to a whole food plant-based diet alongside guideline-directed medical therapy. Over five and a half months, she lost 22.7 kg, reversed her diabetes without diabetes medications, and normalized her left ventricular systolic function. The authors noted that causality cannot be determined from this case report.

Allen KE, Gumber D, Ostfeld RJ Front Nutr, 2019. PMID 31245377

2019 / Narrative review

A 2% absolute increase in energy intake from trans fats is associated with a 23% increase in cardiovascular risk, alongside increased cancer and diabetes risk.

A review of epidemiologic and biochemical evidence evaluated trans fatty acid (TFA) intake and chronic disease risks. A 2% absolute increase in energy intake from trans fat has been associated with a 23% increase in cardiovascular risk. TFAs increase low-density lipoprotein levels, and several epidemiological studies demonstrate that high TFA intake increases the incidence of cancer and diabetes. Complete elimination of TFAs is not possible in a balanced diet due to their natural presence in dairy and meat products.

Shows an association, not proof of cause and effect.

Islam MA, Amin MN, Siddiqui SA, et al. Diabetes Metab Syndr, 2019. PMID 31336535

2019 / Narrative review

A review suggests plant-based diets may reduce the risk of heart disease and possibly cancer among Black individuals in the United States.

This review evaluated the evidence on plant-based diets and health outcomes, examining how these benefits translate to Black individuals in the United States. Although substantial evidence supports plant-based diets in the general population, little research has focused specifically on Black populations. Available data suggest that plant-based diets may reduce the risk of heart disease and possibly cancer in this group. The authors note that more research is needed on cardiovascular risk factors, cancer subtypes, and other chronic diseases, emphasizing the need for culturally appropriate interventions.

Shows an association, not proof of cause and effect.

Sterling SR, Bowen SA Nutrients, 2019. PMID 31810250

2019 / Updated systematic review of meta-analyses

Nut consumption was linked to lower CVD, CHD, and stroke mortality/incidence, and reduced fasting glucose, total cholesterol, and LDL-C in meta-analyses.

An updated electronic search of PubMed/MEDLINE, CINAHL, and Cochrane Library identified seven new meta-analyses examining nut consumption and cardiometabolic diseases. Comparing high with low consumption categories, nut intake significantly decreased CVD mortality (-19% to -25%; n = 4), CHD mortality (-24% to -30%; n = 3), stroke mortality (-17% to -18%; n = 3), CVD incidence (-15% to -19%; n = 4), CHD/CAD incidence (-17% to -34%; n = 8), and stroke incidence (-10% to -11%; n = 6). Compared with control diets, nut consumption significantly reduced fasting glucose (0.08 to 0.15 mmol/L; n = 6), total cholesterol (0.021 to 0.30 mmol/L; n = 10), and LDL-C (0.017 to 0.26 mmol/L; n = 10). Body weight and blood pressure were not significantly affected.

Shows an association, not proof of cause and effect.

Kim Y, Keogh JB, Clifton PM Int J Environ Res Public Health, 2019. PMID 31817639

2019 / Narrative review

A review suggests that a plant-based diet may serve as a valuable tool for managing atrial fibrillation risk factors.

Atrial fibrillation affects an estimated 34 million individuals globally and carries a significant burden of morbidity and mortality. This review examines evidence regarding the use of a whole-food plant-based diet—emphasizing grains, legumes, vegetables, fruits, and nuts while excluding most or all animal products—for managing atrial fibrillation risk factors. It highlights effects on cardiovascular and metabolic factors including hypertension, coronary artery disease, diabetes, obesity, inflammation, and subclinical atherosclerosis.

Storz MA, Helle P J Arrhythm, 2019. PMID 31844466

2018 / Review

Berry anthocyanin data show potential cardiovascular benefits, but longer-term randomised controlled trials are lacking.

Over half of cardiovascular events could be prevented by improved diet, and prospective studies supported by randomized controlled trials suggest fruit and vegetable benefits may stem from flavonoids such as anthocyanins. However, proof of efficacy from longer-term randomized controlled trials and an understanding of differential metabolism are distinctly lacking. The review notes that simple dietary change, including incorporating a few portions of anthocyanin-rich fruit, could have a significant impact at a public health level.

Cassidy A Mol Aspects Med, 2018. PMID 28483533

2018 / Narrative review / commentary

A healthy lifestyle including diet could prevent approximately 80% of chronic disease and premature death.

This article discusses the role of lifestyle choices in health and chronic disease prevention. It notes that approximately 80% of chronic disease and premature death could be prevented by avoiding smoking, engaging in physical activity, and following a healthful dietary pattern. Cardiovascular disease, diabetes, stroke, dementia, and cancer are all influenced by lifestyle. The author argues for a global coalition of experts to clarify confusing nutrition messages and promote health-promoting diet and lifestyle patterns.

Katz DL, Frates EP, Bonnet JP, et al. Am J Health Promot, 2018. PMID 28523941

2018 / Narrative review

Lifestyle medicine addressing nutrition and activity is advocated to prevent and manage chronic illnesses like cardiovascular disease, cancer, and diabetes.

This review describes the practice of lifestyle medicine and its impact on chronic diseases such as cardiovascular disease, cancer, and type 2 diabetes. The authors highlight that most chronic illnesses stem from poor nutrition and physical inactivity. They discuss the economic benefits of prevention-based lifestyle medicine and argue that it should become the primary approach to managing and preventing chronic conditions.

Bodai BI, Nakata TE, Wong WT, et al. Perm J, 2018. PMID 29035175